Joint Commercialization Team definition

Joint Commercialization Team or "JCT" shall mean that body established pursuant to Section 3.3 below.
Joint Commercialization Team or “JCT” shall have the meaning ascribed to it in Section 4.4.
Joint Commercialization Team. Joint Commercialization Team shall mean the team established pursuant to Section 4.3(a).

Examples of Joint Commercialization Team in a sentence

  • All such responses shall be made in accordance with the procedures established by the Joint Project Team and the Joint Commercialization Team.

  • Except as required by law, each Party agrees that it shall not publish or present the results of Development work related to Licensed Product, including but not limited to, studies or clinical trials carried out by such Party as part of the collaboration under this Agreement without the opportunity for prior review by the other Party and the approval of the Joint Project Team, Joint Commercialization Team or the JSC, as the case may be.

  • Each Party will appoint a representative with expertise in the areas of accounting, cost allocation, budgeting and financial reporting to the Joint Commercialization Team.

  • The JPC shall exist until the termination of this Agreement, provided that at such time as the Joint Project Team no longer exists, the JPC shall become a subcommittee of the Joint Commercialization Team.

  • Each Party shall notify the other Party of any complaint received by it in sufficient detail and in accordance with the timeframes and procedures for reporting established by the Joint Project Team and the Joint Commercialization Team, and in any event in sufficient time to allow the Party that holds the applicable regulatory filing to comply with any and all regulatory requirements imposed upon it in any country.

  • Such representatives shall provide services to and consult with the Joint Commercialization Team in order to address the financial, budgetary and accounting issues which arise in connection with the Commercialization Plan, each Annual Commercialization Plan/Budget and the Financial Planning, Accounting and Reporting Procedures attached hereto as Exhibit B, and updates thereto.

  • The Company is a British Virgin Islands company and is qualified to do business in every jurisdiction in which the failure to so qualify would reasonably be expected to have a material adverse effect on the financial condition, operating results or assets of the Company.

  • Each Party shall provide to the responsible Party under this Section with data on all adverse drug experience reports related to Licensed Product in each case in accordance with procedures established by the Joint Project Team or the Joint Commercialization Team or pursuant to an adverse event reporting agreement entered into by the Parties.

  • Once such abstracts, manuscripts or presentations have been reviewed by each Party and have been approved for publication by the Joint Project Team, the Joint Commercialization Team, or the JSC, as the case may be, the same abstracts, manuscripts or presentations do not have to be provided again to the other Party for review for a later submission for publication.

  • At the earlier of either one (1) year prior to the expected first commercial sale or Antegren or, as applicable, other Licensed Product or ninety (90) days after the start of any Phase III Clinical Trial for Antegren or, as applicable, other Licensed Product, a Joint Commercialization Team, or JCT, will be formed, comprised of an equal number of representatives of each Party, the total number of which will be between three (3) and five (5).


More Definitions of Joint Commercialization Team

Joint Commercialization Team or “JCT” means the joint commercialization team as more fully described in Section 4.2.

Related to Joint Commercialization Team

  • Joint Commercialization Committee or “JCC” has the meaning set forth in Section 2.1(a).

  • Commercialization or “Commercialize” means any and all activities undertaken at any time for a particular Licensed Product and that relate to the manufacturing, marketing, promoting, distributing, importing or exporting for sale, offering for sale, and selling of the Licensed Product, and interacting with Regulatory Authorities regarding the foregoing.

  • Development Team means the entities and professionals assembled to develop and manage the Project, typically including the Applicant, Owner, Developer(s), Co-Developer(s) and general partner or any other related entities in which the Developer or Co-Developer has an identity of interest or a Controlling Interest.

  • Commercialization Plan has the meaning set forth in Section 6.2.

  • Development Program means the implementation of the development plan.

  • JCC has the meaning set forth in Section 2.1.

  • Development Activities means those activities which are normally undertaken for the development, construction, rehabilitation or conversion of buildings for residential purposes, including the acquisition of property;

  • Development Plan has the meaning set forth in Section 3.2.

  • Research Program has the meaning set forth in Section 2.1.

  • Collaboration has the meaning set forth in Section 2.1.

  • Development Committee shall have the meaning set forth in Section 3.4.1.

  • JSC has the meaning set forth in Section 3.1.

  • JDC has the meaning set forth in Section 3.2.

  • Development Plans has the meaning set forth in Section 3.2.

  • Research Plan shall have the meaning set forth in Section 2.1.

  • Joint Development Committee or “JDC” has the meaning set forth in Section 3.10.

  • Collaboration Technology means all Collaboration Patents and Collaboration Know-How.

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Medical Affairs Activities means, with respect to any country or other jurisdiction in the Territory, the coordination of medical information requests and field based medical scientific liaisons with respect to Licensed Compounds or Licensed Products, including activities of medical scientific liaisons and the provision of medical information services with respect to a Licensed Compound or Licensed Product.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Development Activity means any activity defined as Development which will necessitate a Floodplain Development Permit. This includes buildings, structures, and non-structural items, including (but not limited to) fill, bulkheads, piers, pools, docks, landings, ramps, and erosion control/stabilization measures.

  • Research Program Term has the meaning set forth in Section 2.2.

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.

  • Clinical means having a significant relationship, whether real or potential, direct or indirect, to the actual rendering or outcome of dental care, the practice of dentistry, or the quality of dental care being rendered to a patient;

  • Collaboration Product means any pharmaceutical product in finished form that contains a Collaboration Compound, either as the sole active ingredient or in combination with one or more other active ingredients, and all present and future formulations, dosages and dosage forms thereof.

  • Clinical Studies means any clinical studies of a Licensed Product conducted on humans.